Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Colfax Corporation    CFX


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Colfax : DJO® Acquires STAR® Ankle and Finger Arthroplasty Systems

11/12/2020 | 08:07am EST

Acquisition adds two new and rapidly growing segments to surgical portfolio

DJO, LLC (DJO or the Company), a leading global provider of medical technologies to get and keep people moving, today announced that it has completed the acquisition of total ankle and finger arthroplasty product lines from international medical technology company Stryker.

The acquisition includes the STAR® total ankle arthroplasty system, a preferred technology worldwide because of its deep and leading clinical outcomes research,1-9 along with Silicone, Surface Replacement (SR) and TACTYS® finger joint arthroplasty products, one of the world’s most comprehensive finger joint arthroplasty portfolios.

Ankle replacements in the U.S. more than doubled last year, in part because ankle implants are becoming the treatment of choice over fusion surgery.10 The STAR ankle is a mobile-bearing total ankle replacement in the U.S. market approved for uncemented use, making it a preferred choice for surgeons and patients who want to help restore mobility.

“Ankle and finger arthroplasty are two fast-growing arthroplasty segments, and this acquisition reflects DJO’s focus on providing market-leading solutions to meet the greater needs of surgeons and their patients,” said Brady Shirley, CEO of DJO®. “This expansion allows us to address a larger patient population and enhances our goal of helping patients return to an active lifestyle.”

STAR System

STAR is one of the first total ankle replacement systems in the market and carries a substantial amount of clinical data over many years demonstrating strong performance.1-9 Intended for use to replace a painful arthritic ankle joint due to osteoarthritis, post-traumatic arthritis or rheumatoid arthritis, STAR’s modular components and positional forgiveness allow for 225 patient-matched configurations with just one surgical technique.

Finger Joint Arthroplasty

The Silicone, Surface Replacement (SR) and TACTYS finger joint arthroplasty portfolio holds a leading global market position with a 20-year clinical history.

  • Silicone constrained silicone elastomer joint replacement devices are designed to replace the affected surface of the PIP and MCP hand joints. The arthroplasty devices have a volar hinge axis intended to create an anatomical balance between the flexor and extensor mechanisms.
  • SR semi-constrained implants are designed to replicate the anatomic joint surfaces of the PIP and MCP joints, preserve bone and reduce disruption to the collateral ligament origins and insertions.
  • TACTYS implant is a total anatomic gliding and modular prosthesis for (PIP) arthritis.

For more information, visit djoglobal.com/surgical.

About DJO®

DJO, a subsidiary of Colfax Corporation (NYSE: CFX), is a leading developer and distributor of high-quality medical devices that provide proven solutions for musculoskeletal health, joint reconstruction, vascular health, and pain management. The Company’s extensive range of products and integrated technologies address the orthopedic continuum of care from performance and mobility to surgical intervention and post-operative rehabilitation; enabling people around the world to regain or maintain their natural motion. For additional information about DJO, please visit www.DJOGlobal.com.


  1. Jastifer, J., & Coughlin, M. (2014). Long-Term Follow-Up of Mobile Bearing Total Ankle Arthroplasty in the United States. Foot & Ankle International, 143-150.
  2. Saltzman, C. L., Mann, R. A., Ahrens, J. E., Amendola, A., Anderson, R. B., Berlet, G. C., . . . Coughlin, M. J. (2009). Prospective Controlled Trial of STAR Total Ankle Replacement versus Ankle Fusion: Initial Results. Foot Ankle Int Foot & Ankle International,30(7), 579-596.
  3. Stryker STAR Op Tech STAR-ST-2_Rev-1
  4. Gougoulias, N., & Maffulli, N. (2015). History of Total Ankle Replacement in North America. Primary and Revision Total Ankle Replacement, 3-13. doi:10.1007/978-3-319-24415-0_1
  5. Mann, J. A., Mann, R. A., & Horton, E. (2011). STAR™ Ankle: Long-Term Results. Foot Ankle Int Foot & Ankle International,32(05), 473-484. doi:10.3113/fai.2011.0473
  6. Chao, J., Choi, J. H., Grear, B. J., Tenenbaum, S., Bariteau, J. T., & Brodsky, J. W. (2015). Early radiographic and clinical results of Salto total ankle arthroplasty as a fixed-bearing device. Foot and Ankle Surgery,21(2), 91-96. doi:10.1016/j.fas.2014.09.012
  7. Internal document :Includes world-wide implantations of all generations; newest generation has over 30,000 world-wide since 1998-2015.
  8. Daniels, T. R., Mayich, D. J., & Penner, M. J. (2015). Intermediate to Long-Term Outcomes of Total Ankle Replacement with the Scandinavian Total Ankle Replacement (STAR). The Journal of Bone and Joint Surgery-American Volume,97(11), 895-903. doi:10.2106/jbjs.n.01077
  9. Brodsky, J. W., Polo, F. E., Coleman, S. C., & Bruck, N. (2011). Changes in Gait Following the Scandinavian Total Ankle Replacement. The Journal of Bone and Joint Surgery (American) J Bone Joint Surg Am,93(20). doi:10.2106/jbjs.j.00347
  10. American College of Foot and Ankle Surgeons, https://www.foothealthfacts.org/article/ankle-replacement-rapidly-on-the-rise


© Business Wire 2020
01/20COLFAX : Unit Acquires Trilliant Surgical
01/19COLFAX : DJO® Acquires Trilliant Surgical
01/19Bank of America Remains Bullish on Industrials for 2021, Sees Potential Upsid..
01/15COLFAX : UBS Adjusts Price Target on Colfax to $45 From $40, Reiterates Buy Rati..
01/07INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Colfax
2020INSIDER TRENDS : 90-Day Insider Buying Trend at Colfax Interrupted with Sale of ..
2020COLFAX : Deutsche Bank Adjusts Price Target for Colfax to $39 From $36, Maintain..
2020COLFAX : Morgan Stanley Adjusts Colfax' Price Target to $39 from $30, Keeps Equa..
2020INSIDER TRENDS : Insider Purchase Continues Colfax Positive Trend
2020COLFAX : DJO, a Subsidiary of Colfax, Acquires LiteCure Laser Therapy for Undisc..
More news
Financials (USD)
Sales 2020 3 070 M - -
Net income 2020 50,8 M - -
Net Debt 2020 2 099 M - -
P/E ratio 2020 105x
Yield 2020 -
Capitalization 4 809 M 4 809 M -
EV / Sales 2020 2,25x
EV / Sales 2021 1,98x
Nbr of Employees 15 000
Free-Float 84,9%
Duration : Period :
Colfax Corporation Technical Analysis Chart | CFX | US1940141062 | MarketScreener
Technical analysis trends COLFAX CORPORATION
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 18
Average target price 43,61 $
Last Close Price 40,60 $
Spread / Highest target 40,4%
Spread / Average Target 7,42%
Spread / Lowest Target -13,8%
EPS Revisions
Managers and Directors
Matthew L. Trerotola President, Chief Executive Officer & Director
Mitchell P. Rales Non-Executive Chairman
Christopher Michael Hix CFO, Treasurer & Senior Vice President
Patrick William Allender Independent Director
Thomas Sinnickson Gayner Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ATLAS COPCO AB11.47%65 981
SANDVIK AB8.15%32 933